Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 1.1T | 1.1T | 1.1T | 1.0T |
Cost of revenue | 957.6B | 1.0T | 985.7B | 922.1B |
Gross profit | 109.6B | 118.3B | 110.6B | 97.9B |
Operating expense | ||||
Research & development | 25.7B | 26.7B | 25.0B | 20.3B |
Selling general and admin | 8.8B | 13.0B | 11.4B | 11.2B |
Other operating expenses | 3.6B | 4.3B | 4.2B | 3.6B |
Operating income | 51.8B | 57.4B | 54.0B | 48.2B |
Non operating interest income | ||||
Income | 3.8B | 4.2B | 4.4B | 4.1B |
Expense | 9.6B | 7.5B | 6.1B | 6.0B |
Other income expense | — | — | — | — |
Pretax income | 32.5B | 38.8B | 37.8B | 35.2B |
Tax provision | 5.4B | 6.5B | 6.0B | 5.8B |
Net income | 27.1B | 32.3B | 31.8B | 29.3B |
Basic EPS | — | 1.7 | 1.8 | 1.6 |
Diluted EPS | — | 1.7 | 1.8 | 1.6 |
Basic average shares | — | 14.1B | 14.0B | 14.3B |
Diluted average shares | — | 14.1B | 14.0B | 14.3B |
EBITDA | 77.8B | 82.7B | 78.4B | 72.5B |
Net income from continuing op. | 27.1B | 32.3B | 31.8B | 29.3B |
Minority interests | -4.9B | -6.2B | -5.1B | -4.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |